Lorcaserin for weight loss: insights into US Food and Drug Administration approval

J Acad Nutr Diet. 2013 Jan;113(1):25-30. doi: 10.1016/j.jand.2012.08.028.

Author

Larry E Miller¹

Affiliation

¹ Miller Scientific Consulting, Inc, Arden, NC 28704, USA. larry@millerscientific.com

PMID: 23260720
DOI: 10.1016/j.jand.2012.08.028

No abstract available

MeSH terms

Anti-Obesity Agents / adverse effects
Anti-Obesity Agents / therapeutic use*
Benzazepines / adverse effects
Benzazepines / therapeutic use*
Drug Approval*
Humans
Obesity / drug therapy*
Obesity / epidemiology
Serotonin 5-HT2 Receptor Agonists / adverse effects
Serotonin 5-HT2 Receptor Agonists / therapeutic use
Treatment Outcome
United States
United States Food and Drug Administration

Substances

Anti-Obesity Agents
Benzazepines
Serotonin 5-HT2 Receptor Agonists
lorcaserin